Most Viewed Articles

A Rare Case Mimicking Collecting System Tumor: Antopol-Goldman Lesion
  • Kamil Gökhan Şeker
  • Emre Şam
  • Osman Özdemir
  • İsmail Yiğitbaşı
  • İsmail Evren
  • Ekrem Güner
  • Volkan Tuğcu
Bull Urooncol 2018; 17: 150-152 DOI: 10.4274/uob.1052
Preoperative Factors Related to Stage and Grade Increase in D’Amico Low-Risk and Intermediate-Risk Group Patients
  • Serdar Çelik
  • Ozan Bozkurt
  • Ömer Demir
  • Burçin Tuna
  • Kutsal Yörükoğlu
  • Güven Aslan
Bull Urooncol 2016; 15: 148-153 DOI: 10.4274/uob.738
What is the Prostate-Specific Antigen Cut-Off Value to Detect Clinically Significant Prostate Cancer According to Age in Turkey?
  • Turgay Ebiloğlu
  • Engin Kaya
Bull Urooncol 2018; 17: 49-53 DOI: 10.4274/uob.970
Is Preoperative Neutrophil Lymphocyte Ratio a Reliable Prognostic Parameter for Localized Prostate Cancer?
  • Tümay İpekçi
  • Mustafa Yüksel
  • Murat Uçar
  • Ahmet Tunçkıran
  • Zafer Kozacıoğlu
  • Ramazan Yavuz Akman
Bull Urooncol 2017; 16: 119-122 DOI: 10.4274/uob.900
Determination of Six Transmembrane Protein of Prostate 2 Gene Expression and Intracellular Localization in Prostate Cancer
  • Bora İrer
  • Ömer Demir
  • Aykut Kefi
  • Güven Aslan
Bull Urooncol 2017; 16: 112-118 DOI: 10.4274/uob.890
The Expression Frequency of Androgen Receptor, c-erbB2 and CD117 in Acinar Adenocarcinoma of Prostate and Normal Prostate Tissue and It’s Clinical Importance
  • Hülya Savaş Mutlu
  • Oğuz Aydın
  • Sancar Barış
  • Sevgi Canbaz
  • Filiz Karagöz
Bull Urooncol 2015; 14: 245-250 DOI: 10.4274/uob.376
Neutropenic Fever, Skin and Eye Toxicities Develops During Docetaxel Treatment in Metastatic Prostate Cancer: A Case Report
  • Erdem Şen
  • İrem Öner
  • Özlem Ata
Bull Urooncol 2017; 16: 133-136 DOI: 10.4274/uob.908
BCG komplikasyonları ve başa çıkma
  • Uğur Yücetaş
  • Gökhan Toktaş
Bull Urooncol 2011; 10: 23-25
Rare Benign and Uncertain Malignant Potential Tumors of Bladder: Review of the Literature
  • Cem Yücel
  • Mehmet Zeynel Keskin
Bull Urooncol 2017; 16: 123-126 DOI: 10.4274/uob.673
Assessment of the Relationship Between Serum Prostate-Specific Antigen Level and Serum Fasting Glucose, Total Cholesterol and Neutrophil-Lymphocyte Ratio in Men Aged 50-70 Years with Prostate-Specific Antigen Level 0-10 ng/mL without Prostate Cancer Diagnosis
  • Bora İrer
Bull Urooncol 2018; 17: 59-62 DOI: 10.4274/uob.999
2017 Author Index
Bull Urooncol 2017; 16: 0-0
Society of Urooncology nomogram for kidney cancer – the user's manual
  • Özgür Yaycıoğlu
Bull Urooncol 2013; 12: 151-154
Gleason Score Correlation Between Prostate Biopsy and Radical Prostatectomy Specimens
  • Erdem Öztürk
  • Taha Numan Yıkılmaz
Bull Urooncol 2018; 17: 1-4 DOI: 10.4274/uob.921
A Rare Presentation of Germ Cell Neoplasia: Persistant Müllerian Duct Syndrome
  • Alp Tuna Beksaç
  • Muhammet Irfan Dönmez
  • Çisel Aydın
  • Dilek Ertoy Baydar
  • Mustafa Sertaç Yazıcı
  • Ali Ergen
  • Bülent Akdoğan
Bull Urooncol 2017; 16: 101-104 DOI: 10.4274/uob.825
‘Nanotechnology Applications’ in the Treatment of Prostate Cancer
  • Ali Furkan Batur
  • Kerem Gencer Kutman
  • Mustafa Suat Bolat
Bull Urooncol 2015; 14: 150-155 DOI: 10.4274/uob.375
Active Surveillance in Prostate Cancer
  • Volkan İzol
  • Nebil Akdoğan
Bull Urooncol 2017; 16: 127-132 DOI: 10.4274/uob.820
Mycobacterium Brumae Extract Fractions with Potential Immunotherapeutic Activity for Bladder Cancer
  • Zeliha Ertürk
  • Esra Büber
  • Haluk Özen
  • Ömür Çelikbıçak
  • Bekir Salih
  • N. Leyla Açan
Bull Urooncol 2017; 16: 70-76 DOI: 10.4274/uob.905
Effects and Mechanisms of Checkpoint Inhibitors (CTLA-4, PD-1 and PD-L1 Inhibitors) as New Immunotherapeutic Agents for Bladder Cancer
  • Serdar Çelik
  • Zekiye Sultan Altun
  • Safiye Aktaş
Bull Urooncol 2018; 17: 18-25 DOI: 10.4274/uob.947
Evaluation of the Relationship Between Duration of Smoking and Clinical and Pathologic Characteristics of Bladder Cancer at Diagnosis
  • Bora İrer
  • Filiz Dağ
  • Güven Aslan
Bull Urooncol 2017; 16: 108-111 DOI: 10.4274/uob.870
Do Length and Tumor Grades of Positive Surgical Margin Have an Impact on Biochemical Recurrence After Prostatectomy?
  • Murat Yavuz Koparal
  • Cenk Acar
  • Betül Ögüt
  • Eda Tokat
  • Fatih Bıçaklıoğlu
  • İpek Işık Gönül
  • Ali Furkan Batur
  • Tevfik Sinan Sözen
Bull Urooncol 2017; 16: 86-91 DOI: 10.4274/uob.859
Current Status of Oligometastatic Prostate Cancer: Risk Factors and Treatment Approaches
  • Fuat Kızılay
Bull Urooncol 2018; 17: 105-112 DOI: 10.4274/uob.1088
Long-Term Outcomes of Patients Who Underwent Ureterocutaneostomy
  • Fuat Kızılay
  • Adnan Şimşir
  • İbrahim Cüreklibatır
  • Çağ Çal
Bull Urooncol 2018; 17: 54-58 DOI: 10.4274/uob.978
Relationship Between Human Papilloma Virus and Bladder Cancer
  • Osman İnci
  • Ebru Taştekin
  • Hakan Akdere
Bull Urooncol 2017; 16: 92-94 DOI: 10.4274/uob.556
Evaluation of General Characteristics of Renal Cell Carcinoma Patients: A Single Center Experience
  • Ümmügül Üyetürk
  • Tuba Taslamacıoğlu Duman
  • Burak Yılmaz
  • Nadire Küçüköztaş
  • Uğur Üyetürk
Bull Urooncol 2018; 17: 45-48 DOI: 10.4274/uob.957
2017 Subject Index
Bull Urooncol 2017; 16: 0-0
Reflection of Adjuvant Treatment Approaches for Early Stage Testis Tumors in Our Clinic
  • İsmail Selvi
  • Erdem Öztürk
  • Taha Numan Yıkılmaz
  • Nurullah Hamidi
  • Halil Başar
Bull Urooncol 2018; 17: 39-44 DOI: 10.4274/uob.973
What are the New Developments in Urinary, Serum and Tissue Biomarkers in Prostate Cancer?
  • Hayrettin Şahin
  • Mehmet Çetinkaya
  • Hasan Deliktaş
Bull Urooncol 2017; 16: 95-100 DOI: 10.4274/uob.620
Metastasis Targeted Therapies in Renal Cell Cancer
  • K. Fehmi Narter
  • Bora Özveren
Bull Urooncol 2018; 17: 26-32 DOI: 10.4274/uob.962
Nursing care following radical cystectomy and urinary diversion
  • Cemile Ulubay Akkaya
Bull Urooncol 2013; 12: 43-45
Comparison of Subcapsular and Total Orchiectomy in Patients with Prostate Cancer
  • Taha Numan Yıkılmaz
  • Erdem Öztürk
  • Nurullah Hamidi
  • Halil Başar
Bull Urooncol 2018; 17: 5-8 DOI: 10.4274/uob.925
2017 Referee Index
Bull Urooncol 2017; 16: 0-0
The Risk Stratifications in Non-Muscle Invasive Bladder Cancer: How Much Accurate are the Methods That We Use? A Multi-Directional View
  • Barış Kuzgunbay
  • Yıldırım Bayazıt
Bull Urooncol 2015; 14: 18-22 DOI: 10.4274/uob.275
Editorial
  • Murat Koşan
Bull Urooncol 2017; 16: 0-0
Positron Emission Tomography in Renal Cell Carcinoma
  • Cigdem Soydal
  • Yüksel Ürün
Bull Urooncol 2018; 17: 68-72 DOI: 10.4274/uob.946
The Relationship between Bladder Cancer and Epigenetic Alterations
  • Ata Özen
  • Ali Ülgen
  • Cavit Can
Bull Urooncol 2017; 16: 17-21 DOI: 10.4274/uob.566
Wunderlich Syndrome, Tuberous Sclerosis-Related Giant Renal Angiomyolipoma Rupture: Case Report
  • Özer Baran
  • Aykut Aykaç
  • Serkan Öner
  • Alpay Aktümen
  • Salih Bürlukkara
  • Mehmet Melih Sunay
  • Hakkı Uğur Özok
Bull Urooncol 2018; 17: 76-78 DOI: 10.4274/uob.994
Incidentally Found Paratesticular Rhabdomyosarcoma: Case Report
  • Halil Çağrı Aybal
  • Taha Numan Yıkılmaz
  • Fatih Hızlı
  • Halil Başar
  • Emin Taha Keskin
Bull Urooncol 2017; 16: 28-30 DOI: 10.4274/uob.720
The Effect of Sex and Age Differences on Pathology Results in Primary Bladder Cancer Patients
  • Hakan Türk
  • Sıtkı Ün
  • Batuhan Ergani
Bull Urooncol 2017; 16: 81-85 DOI: 10.4274/uob.857
ABO Blood Types and Risk of Testicular Cancer in Turkish Population: Preliminary Results
  • Şebnem İzmir Güner
  • Ekrem Güner
Bull Urooncol 2019; 18: 135-137 DOI: 10.4274/uob.galenos.2019.1226
Ongoing Studies of the Bladder Tumor Study Group: An Overview
  • N. Aydın Mungan
  • İlker Tınay
Bull Urooncol 2014; 13: 67-69 DOI: 10.4274/UOB.01
Oncocytic Adrenocortical Carcinoma: A Rare Case Report
  • Oktay Üçer
  • Oğuzcan Erbatu
  • Ayça Tan
  • Talha Müezzinoğlu
Bull Urooncol 2018; 17: 73-75 DOI: 10.4274/uob.975
The Efficiency of Docetaxel Chemotherapy on Castration Resistant Prostate Cancer: Singe Center Experience
  • Evren Süer
  • Nurullah Hamidi
  • Mehmet İlker Gökçe
  • Sümer Baltacı
Bull Urooncol 2017; 16: 77-80 DOI: 10.4274/uob.821
Flüoresan sistoskopi ve tur'un geleceği var mı?
  • Gökhan Özer
Bull Urooncol 2011; 10: 26-30
Initial Outcomes and Assessment of the Transperineal Multiparametric-Magnetic Resonance Imaging/Ultrasonography Fusion Biopsy Method in Diagnosing Clinically-significant Prostate Cancer
  • Mahir B. Özgen
  • Bora Özveren
  • Sertaç Uzel
  • Uğur Altuğ
  • Levent Türkeri
Bull Urooncol 2017; 16: 42-45 DOI: 10.4274/uob.805
Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
  • Elif Atağ
  • Aziz Karaoğlu
  • Ömer Küçük
Bull Urooncol 2017; 16: 57-62 DOI: 10.4274/uob.763
Evaluation of Prostatic Artery Embolization Efficiency in Benign Prostatic Hyperplasia Patients with High Comorbidity
  • İsmail Okan Yıldırım
  • Enes Duman
  • Ali Fırat
  • Hüseyin Çelik
  • Kaya Saraç
Bull Urooncol 2018; 17: 14-17 DOI: 10.4274/uob.937
Risk Factors for Adrenal Invasion in Renal Cell Carcinoma
  • Kaan Çömez
  • Serdar Çelik
  • Ozan Bozkurt
  • Ömer Demir
  • Güven Aslan
  • Kutsal Yörükoğlu
  • İlhan Çelebi
Bull Urooncol 2018; 17: 79-83 DOI: 10.4274/uob.948
Non-Muscle Invasive Bladder Cancer: Diagnosis and Treatment of Highest-Risk Subgroup
  • Yılören Tanıdır
  • İlker Tınay
Bull Urooncol 2015; 14: 50-54 DOI: 10.4274/uob.298
Do the Pain Scores During Transrectal Ultrasound-guided Prostate Rebiopsy Change in Patients with a Prior History of Prostate Biopsy?
  • Dr. Deniz Bolat
  • Dr. Mehmet Erhan Aydın
  • Dr. Bülent Günlüsoy
  • Dr. Tansu Değirmenci
  • Dr. Yusuf Kadir Topçu
  • Dr. İbrahim Küçüktürkmen
  • Dr. Zafer Kozacıoğlu
Bull Urooncol 2017; 16: 4-7 DOI: 10.4274/uob.784
Intravesical Therapies in Non-muscle Invasive Bladder Tumors
  • Serdar Geyik
Bull Urooncol 2019; 18: 24-29 DOI: 10.4274/uob.galenos.2018.1116